
To learn more about Jazz Pharmaceutical’s ZIIHERA, click here.
Register by May 26 for Complimentary Member Pricing!Details >
• AVYXASSIST™ • IncyteCARES • ServierONE Details >
• CMS CLIA Communications Update • We Want Your Comments: SRT for the Treatment of NMSC • Upcoming Events • Upcoming Closure • Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• 2025 CAHPS for MIPS Survey • 2025 QPP Exception Applications Now Available • Suspension of 8 Improvement Activities for MIPS • MLN Matters Details >This edition includes articles on• 340B Savings Must Continue to Drive Local Investment in Healthcare • Verifying the Authenticity of Federal Contacts • Why Price Transparency is a Rare Unifying Issue • Weaponing the OIG • The Undoing of SDoH Reporting Details >
Recent Oncology Related News• Management of Oncology Medical Benefit Drugs Changes - June 1 • Trazimera Preferred Trastuzumab Product - May 12 • Step Therapy Required for Keytruda & Opdivo for NPC- June 18 • Piasky & Tremfya Have Site-of-Care Requirement - June 1 • Alyglo, Amtagvi, & Loqtorzi Have Requirements - Starting June 1 Details >Publications• The Record • BCN Provider News Details >
• Update! Procrit or Epoetin Class Drugs Maintenance • BCBSM Below Cost Reimbursement Details >• 0885 Claims Denied With Reason Code 693 • Procrit or Epoetin Class Drugs Maintenance • Procrit Denials (693) • 505(b)(2) Oncology Products Being Impacted by Prior Auth Details >• May 2025 OfficeLink Update • Drugs Not Covered - And Their Covered Alternatives Details >• Claim Pattern Review Program for Professional Claims • Plans Offered Through HAP CareSource • Pharmacy Information • Preferred Lab Partner • And More Details >Recent Oncology Related News• Preferred Drug List Details >• Update to Supervising Claim Voids • Record Keeping Reminder • MMP Bulletin Details >• Digestive Health Support Platform Available June 1 • Food Delivery Services Covered for Some Members Starting June 1 • Commercial & Medicaid Formulary Changes Taking Effect • May 2025 Billing Policy Updates • And More Details >• Medical Policy Updates • Reimbursement Policy Updates • Pharmacy and Clinical Updates • Advance Notification and Prior Authorization Requirements • And More Details >
• Incyte Zynyz® (retifanlimab-dlwr) • Abbvie Emrelis™ (telisotuzumab vedotin-tllv) • Merck Welireg® (belzutifan) Details >
Encourage Your Patients to Participate!Details >
May 2025 Frequently Asked Questions• 96376 Reported in Conjunction With 96374 or 96375 • Oral Hydration VS Intravenous Hydration Therapy Details >
|